scispace - formally typeset
M

Michael C. Wei

Researcher at Genentech

Publications -  61
Citations -  13643

Michael C. Wei is an academic researcher from Genentech. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 20, co-authored 40 publications receiving 12967 citations. Previous affiliations of Michael C. Wei include Boston University & Washington University in St. Louis.

Papers
More filters
Journal ArticleDOI

Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death

TL;DR: In this article, the authors found that doubly deficient cells are resistant to multiple apoptotic stimuli that act through disruption of mitochondrial function: staurosporine, ultraviolet radiation, growth factor deprivation, etoposide, and the endoplasmic reticulum stress stimuli thapsigargin and tunicamycin.
Journal ArticleDOI

BCL-2, BCL-XL Sequester BH3 Domain-Only Molecules Preventing BAX- and BAK-Mediated Mitochondrial Apoptosis

TL;DR: In mammals, BH3 domain-only molecules activate multidomain proapoptotic members to trigger a mitochondrial pathway, which both releases cytochrome c to activate caspases and initiates caspase-independent mitochondrial dysfunction.
Journal ArticleDOI

tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c

TL;DR: It is demonstrated that tBID functions as a membrane-targeted death ligand in which an intact BH3 domain is required for cytochrome c release, but not for targeting.
Journal ArticleDOI

Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis.

TL;DR: It is demonstrated that a physiologic death stimulus, the withdrawal of interleukin‐3 (IL‐3), resulted in the translocation of monomeric BAX from the cytosol to the mitochondria where it could be cross‐linked as a BAX homodimer and enforced dimerization of BAX overrode the protection by BCL‐XL and IL‐3 to kill cells.